Changes of melanocytic lesions induced by Melanotan injections and sun bed use in a teenage patient with FAMMM syndrome
Keywords:
Melanotan, UV tanning, familial atypical mole and malignant melanoma syndrome, atypical mole, dysplastic nevusAbstract
A 16-year-old girl presented with general skin tanning, multiple dark melanocytic nevi and an enlarging nevus in her left groin following self-injections of Melanotan 2 and attending a UV tanning studio. She had been referred by her GP who was concerned that some of the darkened nevi were potentially malignant.
References
NIH Consensus Conference. Diagnosis and treatment of early melanoma. JAMA. 1992;268(10):1314-9.
Elder DE, Goldman LI, Goldman SC, Greene MH, Clark WH Jr. Dysplastic nevus syndrome: a phenotypic association of sporadic cutaneous melanoma. Cancer. 1980;46(8):1787-94.
International Agency for Research on Cancer Working Group on artificial ultraviolet (UV) light and skin cancer. The association of use of sunbeds with cutaneous malignant melanoma and other skin cancers: a systematic review. Int J Cancer. 2007;120:1116-22.
Cooke KR, Spears GF, Elder DE, Green MH. Dysplastic nevi in a population-based survey. Cancer. 1989;63(6):1240-4.
Kanzler MH, Swelter SM. Malignant melanoma. J Am Acad Dermatol. 2003;48(5):780-3.
Tsao H, Sober AJ. Atypical melanocytic nevi. In: Fitzpatric T, Freedburg IM, eds. Fitzpatrick’s Dermatology in General Medicine, Vol 1. 6th ed. New York: McGraw Hill, 2003:906-16.
Salopek TG. The dilemma of the dysplastic nevus. Dermatol Clin. 2002;20(4): 617-28.
Tripp JM, Kopf AW, Marghoob AA, Bart RS. Management of dysplastic nevi: a survey of fellows of the American Academy of Dermatology. J Am Acad Dermatol. 2002;46(5) 674-82.
Sawyer TK, Sanfilippo PJ, Hruby VJ, et al. 4-Norleucine, 7-D-phenylalanine-alpha-melanocyte-stimulating hormone: a highly potent alpha-melanotropin with ultralong biological activity. Proc Natl Acad Sci USA. 1980;77(10):5754-8.
Clinuvel. Web site. http://www.clinuvel.com/en/scenesse/afamelanotide. Accessed October 4, 2011.
Dorr RT, Lines R, Levine N, et al. Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical stud. Life Sci. 1996;58(20): 1777-84.
Langan EA, Ramlogan D, Jamieson LA, Rhodes LE. Change in moles linked to use of unlicensed “sun tan jab.” BMJ. 2009; 338:b277.
Cousen P, Colver G, Helbling I. Eruptive melanocytic naevi following melanotan injection. Br J Dermatol. 2009;161(3):707-8.
Cardones AR, Grichnik JM. Alpha melanocyte-stimulating hormone-induced eruptive nevi. Arch Dermatol. 2009;145(4):441-4.
Paurobally D, Jason F, Dezfoulian B, Nikkels AF. Melanotan-associated melanoma. Br J Dermatol. 2011;164(6):1403-5.
Downloads
Published
Issue
Section
License
Dermatology Practical & Conceptual applies a Creative Commons Attribution License (CCAL) to all works we publish (http://creativecommons.org/licenses/by-nc/4.0/). Authors retain the copyright for their published work.
How to Cite
Share
